Back

Safety, acceptability, and feasibility of acquiring endothelial cells from guidewires in patients having major surgery or with acute critical illness

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel regulators of vascular functions Vascular Biology and Physiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Charlie Piercy

Guildford (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Endothelial NRG-1 knock-out causes left ventricle dilation in the presence and absence of angiotensin II administration
Mr B. Van Berlo (Antwerp, BE)
Abstract Slides Video
Presentation thumbnail
cAMP/PKA-mediated in vitro angiogenesis: A novel interplay between PKA, RhoA/ROCK, and VEGFR2 signalling
Doctor M. Aslam (Giessen, DE)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction in postmenopausal minipigs with multiple risk factors
Doctor O. Sorop (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Activation, regulation, and effects of the mitochondrial unfolded protein response in endothelial cells
Doctor M. Al Zaidi (Bonn, DE)
Abstract Slides Video
Presentation thumbnail
Effects of BET Inhibition on lung micro-environmental changes in obesity-related pulmonary Arterial Hypertension (PAH)
Doctor M. Telesca (Zurich, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Novel regulators of vascular functions

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Catecholamines induce endothelial dysfunction to promote pro-inflammatory and pro-thrombotic responses: role of the NADPH oxidases/SGLT2 pro-oxidant pathway
thumbnail
Congress Presentation
Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial
thumbnail
Congress Presentation
A novel strategy by pharmacological reprogramming reverses endothelial senescence and improves vascular regeneration

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources